Diplopia
6 drugs1,124 FAERS reportsMedDRA PT
GET
/api/v1/reaction/diplopiaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Diplopia (6)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Dichromate Ion117%
- 2Teprotumumab3105.8%
- 3Pyridostigmine3343.2%
- 4Efgartigimod Alfa1263.1%
- 5Rozanolixizumab252.8%
- 6Ravulizumab3282.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Myasthenia Gravis Crisis3 shared · 0.43
- Myasthenia Gravis4 shared · 0.33
- Eyelid Ptosis2 shared · 0.25
- Therapeutic Response Shortened2 shared · 0.17
- Dysphagia4 shared · 0.08
- Muscular Weakness3 shared · 0.05
- Hospitalisation3 shared · 0.02
- Covid-193 shared · 0.02
- Urinary Tract Infection2 shared · 0.01
- Gait Disturbance2 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.